NOVELION THERAPEUTICS INC.·4

Dec 27, 4:05 PM ET

NOVELION THERAPEUTICS INC. 4

4 · NOVELION THERAPEUTICS INC. · Filed Dec 27, 2016

Insider Transaction Report

Form 4
Period: 2016-12-22
Louis Roger
See Remarks
Transactions
  • Award

    Stock Option (right to buy)

    2016-12-22+41,74041,740 total
    Exercise: $8.65Exp: 2026-12-22Common Shares (41,740 underlying)
Footnotes (2)
  • [F1]Each option has an exercise price equal to the closing price of a common share of the Issuer on the Nasdaq Global Select Market on the grant date.
  • [F2]Subject, with limited exceptions, to the Reporting Person's continued employment with the Issuer or one of its affiliates, 13,913 common shares underlying this stock option award will vest on December 22, 2017, 13,913 common shares underlying this stock option award will vest on December 22, 2018 and 13,914 common shares underlying this stock option award will vest on December 22, 2019.

Documents

1 file
  • 4
    a4.xmlPrimary

    4